Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

Are fibrotic complications reversible? Scientific Programme
Year: 2019
Authors: Geert D'Haens

Sponsored by ECCO

Artificial Intelligence augmenting Medical Management Scientific Programme
Year: 2019
Authors: Geert Meyfroidt
Assessing and grading postoperative recurrence6th ECCO-ESGAR Ultrasound Workshop - Advanced
Year: 2019
Authors: Stephan Vavricka
Assessing bowel damage in CD from adult to childhoodScientific Programme
Year: 2019
Authors: Anne Griffiths
Best practice in screening for dysplasiaScientific Programme
Year: 2019
Authors: Marietta Iacucci
Breastfeeding and risk of IBD4th D-ECCO Workshop
Year: 2019
Authors: Joana Torres
Can we cure IBD?Scientific Programme
Year: 2019
Authors: Arthur Kaser
Can we prevent IBD?Scientific Programme
Year: 2019
Authors: Jean-Frédéric Colombel
Cancer risk in children with IBD, an under-recognized issueScientific Programme
Year: 2019
Authors: Arie Levine
Complications secondary to intravenous iron infusion in PIBD patient4th D-ECCO Workshop
Year: 2019
Authors: Richard Russell
Crohn’s and the Black death: an evolutionary balance?JCC Podcast
Year: 2019
Authors: Jean-Pierre Hugot et al.

Prof Jean-Pierre Hugot describes his team’s work examining associations between contemporary frequency of NOD2 mutations in populations and estimated rates of death from the plague during the medieval period.

https://academic.oup.com/ecco-jcc/pages/podcast

Keywords:

Crohn’s Disease,
Genetic factors.

Development of an inflammatory bowel disease specific nutrition screening tool (IBD-NST)4th D-ECCO Workshop
Year: 2019
Authors: Catherine Wall
Diet and microbiome in IBD4th D-ECCO Workshop
Year: 2019
Authors: Marjo Campmans-Kuijpers
Distinct IL-13 subgroups in patients with ulcerative colitisJCC Podcast
Year: 2019
Authors: Monica Boirivant et al.

Monica Boirivant describes the work and the thinking behind her team’s demonstration of distinct subgroups of patients with different IL-13 expression in ulcerative colitis, with distinct clinical and microbial profiles and discusses implications for therapeutics in the context of previous negative anti-IL13 studies.

Diverting stoma is enough!8th S-ECCO IBD Masterclass
Year: 2019
Authors: Dieter Hahnloser
Early Surgery in Ileal CD (localised)Transatlantic Talking Heads
Year: 2019
Authors: Fabrizio Michelassi, Peter Irving, Willem Bemelman
ECCO Lecture: Inflammatory Cytokines from Discoveries to TherapiesScientific Programme
Year: 2019
Authors: Charles Dinarello
ECCO RevolutionTalking Heads
Year: 2019
Authors: Renzo Cabrilli, Boris Vucelic, Miquel Gassull
Elastography and CEUS to characterize strictures and abdominal masses in Crohn’s Disease6th ECCO-ESGAR Ultrasound Workshop - Advanced
Year: 2019
Authors: Rune Wilkens
Endoscopic outcomes and therapeutic drug monitoring with Vedolizumab: the Leuven experienceJCC Podcast
Year: 2019
Authors: Bram Verstock et al.

Bram Verstockt reports a large, single centre experience of Vedolizumab use in both UC and CD from Leuven, Belgium with interesting findings for endoscopic outcomes as well as therapeutic drug monitoring.